- Home
- MULN vs OLMA Comparison
MULN vs OLMA Comparison
Compare MULN & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MULN
- OLMA
- Stock Information
- Founded
- MULN 2014
- OLMA 2006
- Country
- MULN United States
- OLMA United States
- Employees
- MULN N/A
- OLMA N/A
- Industry
- MULN Auto Manufacturing
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- MULN Consumer Discretionary
- OLMA Health Care
- Exchange
- MULN Nasdaq
- OLMA Nasdaq
- Market Cap
- MULN 15.1M
- OLMA 465.4M
- IPO Year
- MULN N/A
- OLMA 2020
- Fundamental
- Price
- MULN $1.19
- OLMA $6.10
- Analyst Decision
- MULN
- OLMA Strong Buy
- Analyst Count
- MULN 0
- OLMA 5
- Target Price
- MULN N/A
- OLMA $26.25
- AVG Volume (30 Days)
- MULN 2.1M
- OLMA 1.2M
- Earning Date
- MULN 02-11-2025
- OLMA 11-12-2024
- Dividend Yield
- MULN N/A
- OLMA N/A
- EPS Growth
- MULN N/A
- OLMA N/A
- EPS
- MULN N/A
- OLMA N/A
- Revenue
- MULN $156,570.00
- OLMA N/A
- Revenue This Year
- MULN N/A
- OLMA N/A
- Revenue Next Year
- MULN N/A
- OLMA N/A
- P/E Ratio
- MULN N/A
- OLMA N/A
- Revenue Growth
- MULN N/A
- OLMA N/A
- 52 Week Low
- MULN $1.14
- OLMA $5.56
- 52 Week High
- MULN $1,799.00
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- MULN 27.94
- OLMA 27.05
- Support Level
- MULN $2.11
- OLMA $5.56
- Resistance Level
- MULN $1.57
- OLMA $6.87
- Average True Range (ATR)
- MULN 0.22
- OLMA 0.81
- MACD
- MULN -0.01
- OLMA -0.28
- Stochastic Oscillator
- MULN 3.55
- OLMA 10.12
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and energy solutions. The company strives to make electric vehicles more accessible by building an end-to-end ecosystem that takes care of all aspects of electric vehicle ownership. The Company owns and partners with several synergistic businesses, all working towards the same goal of creating clean and scalable electric vehicles and energy solutions. The company has two segments Bollinger and Mullen/ELMS, which generates revenue.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.